palbociclib
pfizer
['penelope-b']
analysis in penelope-b trial: ctdna after neoadjuvant therapy is associated with very high risk of early relapse, suggesting limited efficacy of adjuvant endocrine therapy . presentation slides from #asco23 available: 
Healing through innovation, competence and partnership. #BreastCancer #CancerResearch #Survival